BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS. As. MARUSHCHAK M.I.

Similar documents
Myocardial Infarction

BIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION. Written by Lenka Fialová, translated by Jan Pláteník

1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).

Biomarkers of myocardial infarction. Dr. Mamoun Ahram Cardiovascular system, 2013

Ischemic Heart Disease

Cardiac Troponin Testing and Chest Pain Patients: Exploring the Shades of Gray

About OMICS International

Challenging Issues in Cardiac Biomarker interpretation. F. Nikaeen. MD interventional Cardiologist

Pharmacologyonline 2: (2010) Newsletter Kakadiya and Shah

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

Internationally indexed journal

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

Classification of lab tests useful in cardiac disease Biochemical markers in Acute Coronary Syndromes (ACS) Redefinition of Myocardial Infarction (MI)

MI Acute occlusion of the proximal left anterior descending (LAD) artery is the cause of 40% to 50% of all MIs. *

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.

Clinical Policy: Cardiac Biomarker Testing for Acute Myocardial Infarction Reference Number: CP.MP.156

Heart failure congestive heart failure, or CHF

GENERAL HISTOLOGY 4. Muscular Tissue

Acute coronary syndromes

Biomarkers of Cardiovascular diseases. By Dr. Gouse Mohiddin Shaik

An update in Cardiac Biomarkers

CARDIAC ENZYMES AND PROTEINS الفريق الطبي األكاديمي. Done By :- Obadah Abubaker & Yousef Qandeel

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

The focus of this week s lab will be pathology of the cardiovascular system.

LAB 4: THE MUSCLE AND CARDIOVASCULAR SYSTEM THE MUSCLE AND CARDIOVASCULAR SYSTEM

Diagnosis and Management of Acute Myocardial Infarction

The Clinical Laboratory Working with Physicians to Improve Patient Care

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Human Troponin I ELISA Kit

7/31/2018. Overview of Next Generation Cardiac Troponin T High Sensitivity. Disclosures. Course Objectives: high sensitive Troponin T assay

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Lec: 21 Biochemistry Dr. Anwar J Almzaiel. Clinical enzymology. Very efficient can increase reaction rates at the order of x 10

CELL INJURY AND CELL DEATH

Use of Biomarkers for Detection of Acute Myocardial Infarction

Topic. Updates on Definition of Myocardial Infarction

Evaluation of the optimal myocardial infarction cutoff for the PATHFAST Troponin I assay of Mitsubishi Kagaku Iatron (MKI)

ACUTE MYOCARDIAL INFARCTION: DEFINITION, DIAGNOSIS, AND THE EVOLUTION OF CARDIAC MARKERS

EDUCATIONAL COMMENTARY UNDERSTANDING THE BENEFITS AND CHALLENGES OF HIGH- SENSITIVITY TROPONIN TESTING IN CLINICAL AND PATHOLOGY SETTINGS

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.


ACUTE CORONARY SYNDROMES

The Diagnostic Value of Troponin T and Myoglobin Levels in Acute Myocardial Infarction: a Study in Turkish Patients

Mohammad Alfarra. Faisal Al Nemri. Hala Al Suqi

Continuing Medical Education Post-Test

Ischemic heart disease (IHD) Dr: Salah Ahmed

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

Setting The setting was secondary care. The economic study was carried out in Hong Kong.

Procedures: LifeSign MI Myoglobin/CK-MB/Troponin I Test. Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature

Ischemic Heart Diseases. Dr. Nabila Hamdi MD, PhD

Muscle Tissue. Xie Fenfen. Department of Histology and Embryology School of Basic Medicine Anhui Medical University

Muscle Tissue and Motion

What about aborted infarction?

9/18/2017. Disclosures. Cardiac Troponin: ER Utilization and the Next Generation

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Thyroidal Trophic Influence Skeletal Muscle. Myosin >>>CLICK HERE<<<

3 IN 1. Myoglobin/CK-MB/Troponin I. Manufactured by. Manufactured for: Princeton BioMeditech Corp U.S. Hwy 1 Monmouth Junction, NJ 08852

Clinical Cardiology Frontiers

Product Information. Instruction for Use. Troponin I ELISA kit Catalog Number: EA Storage Temperature: 2 8 C

Prehospital and Hospital Care of Acute Coronary Syndrome

Pyruvate + NADH + H + ==== Lactate + NAD +

AIMS: CHEST PAIN. Causes of chest pain. Causes of chest pain: Cardiac causes: Acute coronary syndromes pericarditis thoracic aortic dissection

Muscles and Animal Movement

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension

GUIDELINES FOR TROPONIN TESTING: AN EVIDENCE-BASED APPROACH TO DIAGNOSIS AND TREATMENT OF THE ACS PATIENT

Post-Procedural Myocardial Injury or Infarction

Ischemic heart disease

Acute Myocardial Infarction

Medical Biology. Dr. Khalida Ibrahim

Imaging of Coronary Artery Disease: II

Dr. Hany M. Abo-Haded

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Health and Disease of the Cardiovascular system

Acute coronary syndrome (ACS) is a potentially

Principles of Anatomy and Physiology

Skeletal muscle in the light of its structure

Practitioner Education Course

Cardiac Pathology 2: Heart Failure, Ischemic Heart Disease and other assorted stuff. Kris=ne Kra>s, M.D.

Chapter Skeletal Muscle Structure and Function

Clinical enzymology. University of Babylon College of pharmacy Second semester - biochemistry 3 rd class By Dr. Abdulhussien M. K.

Lecture 9A. Muscle structure. Outline

TROPONINS HAVE THEY CHANGED YOUR

Muscle tissue. 1) Striated skeletal muscle tissue. 2) Striated cardiac muscle tissue. 3) Smooth muscle tissue.

Tests I Wish You Had Not Ordered. Scott Girard D.O. FACOI Hospitalist

Acute Coronary Syndrome

Comparison of M yoglobin, Creatine Kinase-MB, and Cardiac Troponin I for Diagnosis of Acute Myocardial Infarction*

National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Muscle Histology. Dr. Heba Kalbouneh Assistant Professor of Anatomy and Histology

Muscle Tissue.

Cardiac Pathology & Rehabilitation

Chapter 10 Muscle Tissue Lecture Outline

About This Chapter. Skeletal muscle Mechanics of body movement Smooth muscle Cardiac muscle Pearson Education, Inc.

Use of enzymes as diagnostic markers. Evaluation of lactate dehydrogenase (LDH) isoenzymes by agarose gel electrophoresis

12 Lead EKG Chapter 4 Worksheet

CHAPTER 6 2/9/2016. Learning Objectives List the four traits that all muscle types have in common.

TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

Transcription:

BIOCHEMICAL INVESTIGATIONS IN THE DIAGNOSTICS OF CARDIOVASCULAR DISORDERS As. MARUSHCHAK M.I.

Heart attack symptoms

Acute MI

Measurement of cardiac enzyme levels Measure cardiac enzyme levels at regular intervals, starting on admission and continuing until the peak is reached or until 3 sets of results are negative. Biochemical biomarkers are useful for both diagnosis and prognostication

This plot shows changes in cardiac markers over time after the onset of symptoms. Peak A is the early release of myoglobin or creatine kinase isoenzyme MB (CK-MB) after acute myocardial infarction (AMI). Peak B is the cardiac troponin level after infarction. Peak C is the CK- MB level after infarction. Peak D is the cardiac troponin level after unstable angina. Data are plotted on a relative scale, where 1.0 is set at the myocardial- infarction cutoff concentration. Courtesy of Wu et al (1999). ROC = receiver operating characteristic.

Laboratory Diagnosis of Myocardial Infarction

Measurement of CK-MB levels CK-MB, the isoenzyme specific to the heart muscle, was the principal biomarker of cardiac injury until troponin supplemented it. In the setting of myocardial infarction, plasma CK-MB concentrations typically rise about 4-6 hours after the onset of chest pain. They peak within 12-24 hours and return to baseline levels within 24-48 hours. Serial measurements obtained every 6-8 hours (at least 3 times) are warranted until peak values are determined.

Clinical settings other than acute coronary syndrome, such as trauma, heavy exertion, and skeletal muscle disease (eg, rhabdomyolysis) may elevate CK-MB values. The area under the concentration-time curve for CK-MB created with serial measurements of blood enzyme levels provides a reliable estimate of the size of the infarct. Determination of subforms of CK-MB (CK-MB2 that is more specific to heart muscle) may improve the sensitivity of this test.

Measurement of troponin levels Troponin is part of the contractile apparatus of the myocyte associated with tropomyosin and actin and myosin filaments. Troponin has 3 subunits: TnT, TnI, and TnC. TnI and TnT are normally not detectable in the blood. Measurement of troponin level has both diagnostic and prognostic value. Positive troponin levels are virtually diagnostic of myocardial infarction in the most recent revisions of the ACC/AHA guidelines, as they are without equal in terms of combined specificity and sensitivity in diagnosing myocardial infarction. Elevated troponin levels might help in identifying patients who might greatly benefit from aggressive antiplatelet and other adjunctive therapy. Troponin levels are typically measured serially along with CK values.

Measurement of myoglobin levels Myoglobin is not cardiac specific, but it may be detected as early as 2 hours after myocardial necrosis starts. Myoglobin results should be supplemented with other more specific cardiac biomarkers, such as CK-MB or troponin. Myoglobin values have a high negative predictive value when blood is sampled in the first 4-8 hours after onset.

Lactate dehydrogenase Enzyme isoforms LDH-1 (4H) - in the heart LDH-2 (3H1M) - in the reticuloendothelial system LDH-3 (2H2M) - in the lungs LDH-4 (1H3M) - in the kidneys LDH-5 (4M) - in the liver and striated muscle

Time from Onset Microscopic Morphologic Finding in MI 1-3 Hours Wavy myocardial fibers 2-3 Hours Staining defect with tetrazolium or basic fuchsin dye 4-12 Hours 18-24 Hours 24-72 Hours 3-7 Days Coagulation necrosis with loss of cross striations, contraction bands, edema, hemorrhage, and early neutrophilic infiltrate Continuing coagulation necrosis, pyknosis of nuclei, and marginal contraction bands Total loss of nuclei and striations along with heavy neutrophilic infiltrate Macrophage and mononuclear infiltration begin, fibrovascular response begins 10-21 Days Fibrovascular response with prominent granulation tissue 7 Weeks Fibrosis

Histologic section of the myocardium showing a cross- section of coronary artery affected by atherosclerosis and myocyte hypertrophy

Histologic section of an autopsy myocardial specimen from a patient with long-standing hypertension and associated coronary artery disease. The slide shows myocardial hypertrophy, contraction bands (typical of left ventricular hypertrophy), and "car box" nuclei.

Progressive build-up of plaque in coronary artery